CTSI

Pittsburgh, United States Founded: 2006 • Age: 20 yrs Acquired By Varian Medical Systems
Clinical and administrative solutions for cancer treatment are provided.

About CTSI

CTSI is a company based in Pittsburgh (United States) founded in 2006 by Peter Ellis and Stanley Marks, and was acquired by Varian Medical Systems in May 2019. Clinical and administrative solutions for cancer treatment are provided. CTSI has raised $2 million across 1 funding round from investors including Varian and TPG. The company has 5 employees.

Company details

CTSI was founded in 2006 in Pittsburgh, United States, within the healthcare sector focused on oncology. A network of cancer treatment facilities has been established, including the flagship American Oncology Institute. Services offered encompass radiation oncology, medical oncology, surgical oncology, diagnostics, and support care for complex diseases. Operations are centered on clinical and administrative solutions to support treatment processes.

  • Headquarters Pittsburgh, United States
  • Employees 5
  • Founders Peter Ellis, Stanley Marks
  • Stage Acquired
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website cancertreatmentservices.com
  • Acquired by Varian Medical Systems (May 2019)
Key Metrics
  • Total Equity Funding
    $2M (USD)

    in 1 rounds

  • Latest Funding Round
    $2M (USD), Seed

    Mar 2009

  • Investors
    Varian

    & 1 more

  • Employee Count
    5
  • Acquired by
    Varian Medical Systems

    & 1 more

    (May 2019)

Funding Insights of CTSI

CTSI has successfully raised a total of $2M through 1 strategic funding round. The most recent funding activity was a Seed round of $2 million completed in March 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2M
  • Total Rounds 1
  • Last Round Seed β€” $2M
  • First Round $2M

    (Mar 2009)

All 1 funding rounds of CTSI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2009$2MSeed––
–
Valuation history

2 investors in total: 2 institutional.

Investors in CTSI

CTSI has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Varian and TPG.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Fund of funds focused on pre-seed and seed-stage companies
1992tpg.comFort Worth, United States
Varian is focused on developing cancer treatment technologies.
1948varian.comPalo Alto, United States
Premium access

Investor details for CTSI

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of CTSI

2 people are tracked at CTSI (2 in leadership); the tracked headcount is 5.

NameRoleGroup
Peter Ellis
Co-Founder & DirectorLeadership
Stanley Marks
Co-Founder & ChairmanLeadership
Premium access

Complete people profiles for CTSI

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of CTSI

4 dated milestones of CTSI across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded CTSI is founded.
  2. Funding First funding round of $2.0M.
  3. Exit Acquired by TPG.
  4. Exit Acquired by Varian Medical Systems.

Web traffic of CTSI

Websites that share an audience with CTSI (cancertreatmentservices.com).

Similar websites

Websites whose visitors overlap most with CTSI. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
citizenshospitals.com
30%
72.9K#549,039View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ctsi

Premium access

Complete news archive for CTSI

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CTSI

CTSI was founded in 2006 and raised its 1st funding round 3 years after it was founded.

CTSI is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.

CTSI is a funded company, having raised a total of $2M across 1 funding round to date. The company's 1st funding round was a Seed of $2M, raised on Mar 2009.

CTSI has 5 employees.

CTSI was founded in 2006 in Pittsburgh, United States, within the healthcare sector focused on oncology. A network of cancer treatment facilities has been established, including the flagship American Oncology Institute. Services offered encompass radiation oncology, medical oncology, surgical oncology, diagnostics, and support care for complex diseases. Operations are centered on clinical and administrative solutions to support treatment processes.

CTSI has 2 investors. Key investors include Varian, and TPG.

Yes. CTSI was acquired by Varian Medical Systems in May 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available